At Janssen we are focused on you, the patient. And that means analysing your symptoms, reactions and pain points, to better understand your health journey. Using data from medical records, surveys, apps and other sources – as well as research trials – we generate real-world evidence (RWE) to help improve healthcare decisions and therapeutics to help you and your loved ones.
Real-world evidence (RWE) is evidence about the usage and potential benefits or risks of a medical product or technology, derived from the analysis and/or synthesis of real-world data (RWD).
RWE is created by addressing specific research questions through the scientific analysis of real-world data (RWD), rather than through randomised controlled trials (RCTs).
RWE complements RCTs to support the healthcare decision-making process. And while RCTs help to answer the question ‘Is this drug/technology safe and effective for a specific use?’, RWE helps address the question ‘How well does this drug/technology work in everyday life?’
How is real-world evidence generated?
RWE is the result of analysing and/or synthesising RWD. Evaluating RWE for decision-making depends not only on the evaluation of the methodologies used to generate the evidence, but also on the reliability and relevance of the underlying RWD.
Analytics & methods
RWD is collected from a variety of sources, such as (electronic) medical records, health surveys, administrative claims, prospective cohorts, disease and/or patient registries, apps, wearables etc.
RWD from these sources can provide important information about patient experience and treatment implementation. However, in order to be used as evidence, relevant data, of the highest quality and integrity, must be analysed using the appropriate methods to address a specific research question to ensure the generated results are robust and reliable.
Janssen and RWE
At Janssen, we use RWE in a transparent way and in collaboration with the scientific research community to complement the information we get from randomised controlled trials (RCTs). This allows us to make better-informed healthcare decisions and to improve disease understanding and treatment, thereby improving clinical practice and health outcomes for patients.
RWE helps us to:
Measure and better understand short- and long-term health outcomes
Capture, analyse and improve management of potential side effects
Understand healthcare practice and reduce costs to healthcare systems
Understand patient journeys in the real world, including key pain points
Shape our clinical development and early drug discovery plans
Improve patient recruitment for our RCTs
Identify new areas of research
HONEUR is a federated network of data partners, set up by Janssen. Its collaborative goal is to unlock the transformational potential of real-world data and improve outcomes for blood cancer patients across Europe.Learn more
EHDEN is a federated network that aims to speed up the health research process. The idea is to revolutionise healthcare by harmonising data from 100 million records to the OMOP common data model.Learn more